PipelinePharma Logo

Generics 23

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

L-asparaginase manufacturers

23 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

23 products found

l-asparaginase

Vials, lyophilized injection 10000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

Established in 2021, this GMP manufacturer is a leading CTD dossier owner and manufacturer, supplying high-quality pharmaceutical products across multiple countries and regions worldwide. Specializing in cytotoxic products, it operates advanced production lines for liquid injections, lyophilized injections, tablets, and capsules. As a CTD dossier owner and manufacturer, it adheres to strict regulatory standards, holding GMP approvals from WHO cGMP, ISO 9001:2015, and authorities in the Philippines, Cambodia, Kenya, Sri Lanka, and Syria. This GMP manufacturer, as a CTD dossier owner and manufacturer, ensures excellence in pharmaceutical development.

l-asparaginase

Injection 750 IU/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Comments
Liposomal Injection
Manufacturer #30013
The company, established in 2016 and later restructured as a private limited entity in 2018, specializes in manufacturing APIs, advanced intermediates, and finished dosage forms. With robust relationships in the pharmaceutical industry, it has built a strong customer base of over 50 clients and achieved an annual turnover exceeding 200 crore. The company operates extensive facilities capable of scaling from lab-scale development to bulk production, supporting its global expansion strategy. Committed to ethical practices and social responsibility, the company aims to make healthcare affordable and accessible worldwide, with export markets across Asia, Latin America, and Africa.

Manufacturer usually replies in 40 days

l-asparaginase

Vials, lyophilized injection 5000 IU, 10000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013
The company, established in 2016 and later restructured as a private limited entity in 2018, specializes in manufacturing APIs, advanced intermediates, and finished dosage forms. With robust relationships in the pharmaceutical industry, it has built a strong customer base of over 50 clients and achieved an annual turnover exceeding 200 crore. The company operates extensive facilities capable of scaling from lab-scale development to bulk production, supporting its global expansion strategy. Committed to ethical practices and social responsibility, the company aims to make healthcare affordable and accessible worldwide, with export markets across Asia, Latin America, and Africa.

Manufacturer usually replies in 40 days

Want to see all 23 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible